133 related articles for article (PubMed ID: 2504466)
1. Differential biotransformation of glyceryl trinitrate by red blood cell-supernatant fraction and pulmonary vein homogenate.
Marks GS; McLaughlin BE; MacMillan HF; Nakatsu K; Brien JF
Can J Physiol Pharmacol; 1989 May; 67(5):417-22. PubMed ID: 2504466
[TBL] [Abstract][Full Text] [Related]
2. Biotransformation of glyceryl trinitrate and elevation of cyclic GMP precede glyceryl trinitrate-induced vasodilation.
Kawamoto JH; McLaughlin BE; Brien JF; Marks GS; Nakatsu K
J Cardiovasc Pharmacol; 1990 May; 15(5):714-9. PubMed ID: 1692930
[TBL] [Abstract][Full Text] [Related]
3. Vascular and anti-platelet actions of 1,2- and 1,3-glyceryl dinitrate.
Salvemini D; Pistelli A; Anggard E
Br J Pharmacol; 1993 Nov; 110(3):937-42. PubMed ID: 8298817
[TBL] [Abstract][Full Text] [Related]
4. Biotransformation of glyceryl trinitrate occurs concurrently with relaxation of rabbit aorta.
Brien JF; McLaughlin BE; Breedon TH; Bennett BM; Nakatsu K; Marks GS
J Pharmacol Exp Ther; 1986 May; 237(2):608-14. PubMed ID: 3084761
[TBL] [Abstract][Full Text] [Related]
5. Biotransformation of glyceryl trinitrate by rat brain homogenate.
Marks GS; McLaughlin BE; Nakatsu K; Brien JF
Can J Physiol Pharmacol; 1992 Jun; 70(6):935-7. PubMed ID: 1423038
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of glyceryl trinitrate-induced vasodilation. I. Relationship between drug biotransformation, tissue cyclic GMP elevation and relaxation of rabbit aorta.
Brien JF; McLaughlin BE; Kobus SM; Kawamoto JH; Nakatsu K; Marks GS
J Pharmacol Exp Ther; 1988 Jan; 244(1):322-7. PubMed ID: 2826771
[TBL] [Abstract][Full Text] [Related]
7. Tissue disposition of glyceryl trinitrate, 1,2-glyceryl dinitrate, and 1,3-glyceryl dinitrate in tolerant and nontolerant rats.
Torfgård KE; Ahlner J; Axelsson KL; Norlander B; Bertler A
Drug Metab Dispos; 1992; 20(4):553-8. PubMed ID: 1356734
[TBL] [Abstract][Full Text] [Related]
8. Role of hemoglobin in the differential biotransformation of glyceryl trinitrate and isosorbide dinitrate by human erythrocytes.
Bennett BM; Brien JF; Nakatsu K; Marks GS
J Pharmacol Exp Ther; 1985 Jul; 234(1):228-32. PubMed ID: 3925128
[TBL] [Abstract][Full Text] [Related]
9. Interaction of glyceryl trinitrate and sodium nitroprusside with bovine pulmonary vein homogenate and 10,000 x g supernatant: biotransformation and nitric oxide formation.
Marks GS; McLaughlin BE; Brown LB; Beaton DE; Booth BP; Nakatsu K; Brien JF
Can J Physiol Pharmacol; 1991 Jun; 69(6):889-92. PubMed ID: 1913335
[TBL] [Abstract][Full Text] [Related]
10. Biotransformation of glyceryl trinitrate to glyceryl dinitrate by human hemoglobin.
Bennett BM; Nakatsu K; Brien JF; Marks GS
Can J Physiol Pharmacol; 1984 Jun; 62(6):704-6. PubMed ID: 6430533
[TBL] [Abstract][Full Text] [Related]
11. The role of nitric oxide formation in organic nitrate-induced vasodilation and organic nitrate tolerance.
Marks GS; Nakatsu K; McLaughlin B; Kawamoto J; Slack C; Brien JF
Z Kardiol; 1989; 78 Suppl 2():18-21; discussion 64-7. PubMed ID: 2555978
[TBL] [Abstract][Full Text] [Related]
12. Requirement for reduced, unliganded hemoprotein for the hemoglobin- and myoglobin-mediated biotransformation of glyceryl trinitrate.
Bennett BM; Kobus SM; Brien JF; Nakatsu K; Marks GS
J Pharmacol Exp Ther; 1986 May; 237(2):629-35. PubMed ID: 3084763
[TBL] [Abstract][Full Text] [Related]
13. Biotransformation of glyceryl trinitrate and isosorbide dinitrate in vascular smooth muscle made tolerant to organic nitrates.
Slack CJ; McLaughlin BE; Brien JF; Marks GS; Nakatsu K
Can J Physiol Pharmacol; 1989 Nov; 67(11):1381-5. PubMed ID: 2516767
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of glyceryl trinitrate-induced vasodilation. II. Lack of evidence for specific binding of GTN to bovine pulmonary vein.
Kawamoto JH; Brien JF; Marks GS; Nakatsu K
J Pharmacol Exp Ther; 1988 Jan; 244(1):328-34. PubMed ID: 3121848
[TBL] [Abstract][Full Text] [Related]
15. Plasma concentrations of glyceryl trinitrate and its dinitrate metabolites after sublingual administration to volunteers. Simultaneous determination of glyceryl trinitrate and its dinitrate metabolites.
Jensen KM; Dahl JB
Arzneimittelforschung; 1994 Aug; 44(8):951-3. PubMed ID: 7945539
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of glyceryl trinitrate and its two dinitrate metabolites in conscious dogs.
Lee FW; Salmonson T; Metzler CH; Benet LZ
J Pharmacol Exp Ther; 1990 Dec; 255(3):1222-9. PubMed ID: 2124621
[TBL] [Abstract][Full Text] [Related]
17. Relationship between biotransformation of glyceryl trinitrate and cyclic GMP accumulation in various cultured cell lines.
Bennett BM; Leitman DC; Schröder H; Kawamoto JH; Nakatsu K; Murad F
J Pharmacol Exp Ther; 1989 Jul; 250(1):316-23. PubMed ID: 2545862
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of NADPH-cytochrome P450 reductase and glyceryl trinitrate biotransformation by diphenyleneiodonium sulfate.
McGuire JJ; Anderson DJ; McDonald BJ; Narayanasami R; Bennett BM
Biochem Pharmacol; 1998 Oct; 56(7):881-93. PubMed ID: 9774150
[TBL] [Abstract][Full Text] [Related]
19. Tolerance development and arterial and venous tissue-/plasma levels of glyceryl trinitrate and glyceryl dinitrate in patients treated with nitroglycerin infusion.
Torfgård KE; Svedjeholm R; Håkansson E; Ahlner J
Arzneimittelforschung; 1995 Sep; 45(9):963-6. PubMed ID: 7488313
[TBL] [Abstract][Full Text] [Related]
20. Carbon monoxide does not inhibit glyceryl trinitrate biotransformation by or relaxation of aorta.
Liu Z; Brien JF; Marks GS; McLaughlin BE; Nakatsu K
Eur J Pharmacol; 1992 Jan; 211(1):129-32. PubMed ID: 1618261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
